Molecular Methods To Improve Diagnosis and Identification of Mucormycosis
Sarah P. Hammond(Dana-Farber Cancer Institute), Francisco M. Marty(Brigham and Women's Hospital), Danny A. Milner(Union for International Cancer Control), Ralf Bialek, Eva M. Petschnigg(Brigham and Women's Hospital), Lindsey R. Baden(Brigham and Women's Hospital)
Cited by 196
Related Papers
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma
|Nature|2005|1.5k
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
|Science|2022|1.2k
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
|New England Journal of Medicine|2017|1.2k